Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-10-20

Clinical Trial Update: Phase IB Metformin, Digoxin, Simvastatin in Solid Tumors [Phase 1]

View source ↗

Summary

Phase Ib study evaluating a combination of metformin, digoxin, and simvastatin in advanced pancreatic cancer and other solid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DIGOXIN (Digoxin)
  • SIMVASTATIN (SIMVASTATIN)
  • metformin (metformin)

Snippet

Sponsor: Danae Hamouda, MD | Conditions: Advanced Pancreatic Cancer, Advanced Solid Tumor | Phase 1 | Status: ACTIVE_NOT_RECRUITING